Global Nuclear Medicine & Radiopharmaceuticals Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Nuclear Medicine & Radiopharmaceuticals market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.
The major players in Chian Nuclear Medicine & Radiopharmaceuticals market include China Isotope & Radiation, Shanghai Atom Kexing, Advanced Molecular-imaging Solution, etc. Beijing and Chengdu are main markets, they occupy about 65% of the whole market. Diagnostic is the main type, with a share about 80%. Cardiology is the main application, which holds a share about 40%.
The Global Info Research report includes an overview of the development of the Nuclear Medicine & Radiopharmaceuticals industry chain, the market status of Oncology (Diagnostic, Therapeutic), Thyroid (Diagnostic, Therapeutic), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Nuclear Medicine & Radiopharmaceuticals.
Regionally, the report analyzes the Nuclear Medicine & Radiopharmaceuticals markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Nuclear Medicine & Radiopharmaceuticals market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Nuclear Medicine & Radiopharmaceuticals market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Nuclear Medicine & Radiopharmaceuticals industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Diagnostic, Therapeutic).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Nuclear Medicine & Radiopharmaceuticals market.
Regional Analysis: The report involves examining the Nuclear Medicine & Radiopharmaceuticals market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Nuclear Medicine & Radiopharmaceuticals market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Nuclear Medicine & Radiopharmaceuticals:
Company Analysis: Report covers individual Nuclear Medicine & Radiopharmaceuticals manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Nuclear Medicine & Radiopharmaceuticals This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oncology, Thyroid).
Technology Analysis: Report covers specific technologies relevant to Nuclear Medicine & Radiopharmaceuticals. It assesses the current state, advancements, and potential future developments in Nuclear Medicine & Radiopharmaceuticals areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Nuclear Medicine & Radiopharmaceuticals market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Nuclear Medicine & Radiopharmaceuticals market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Nuclear Medicine & Radiopharmaceuticals product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Nuclear Medicine & Radiopharmaceuticals, with price, sales, revenue and global market share of Nuclear Medicine & Radiopharmaceuticals from 2019 to 2024.
Chapter 3, the Nuclear Medicine & Radiopharmaceuticals competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nuclear Medicine & Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Nuclear Medicine & Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Nuclear Medicine & Radiopharmaceuticals.
Chapter 14 and 15, to describe Nuclear Medicine & Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion.
Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.
The major players in Chian Nuclear Medicine & Radiopharmaceuticals market include China Isotope & Radiation, Shanghai Atom Kexing, Advanced Molecular-imaging Solution, etc. Beijing and Chengdu are main markets, they occupy about 65% of the whole market. Diagnostic is the main type, with a share about 80%. Cardiology is the main application, which holds a share about 40%.
The Global Info Research report includes an overview of the development of the Nuclear Medicine & Radiopharmaceuticals industry chain, the market status of Oncology (Diagnostic, Therapeutic), Thyroid (Diagnostic, Therapeutic), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Nuclear Medicine & Radiopharmaceuticals.
Regionally, the report analyzes the Nuclear Medicine & Radiopharmaceuticals markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Nuclear Medicine & Radiopharmaceuticals market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Nuclear Medicine & Radiopharmaceuticals market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Nuclear Medicine & Radiopharmaceuticals industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Diagnostic, Therapeutic).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Nuclear Medicine & Radiopharmaceuticals market.
Regional Analysis: The report involves examining the Nuclear Medicine & Radiopharmaceuticals market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Nuclear Medicine & Radiopharmaceuticals market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Nuclear Medicine & Radiopharmaceuticals:
Company Analysis: Report covers individual Nuclear Medicine & Radiopharmaceuticals manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Nuclear Medicine & Radiopharmaceuticals This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oncology, Thyroid).
Technology Analysis: Report covers specific technologies relevant to Nuclear Medicine & Radiopharmaceuticals. It assesses the current state, advancements, and potential future developments in Nuclear Medicine & Radiopharmaceuticals areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Nuclear Medicine & Radiopharmaceuticals market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Nuclear Medicine & Radiopharmaceuticals market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Diagnostic
- Therapeutic
- Oncology
- Thyroid
- Cardiology
- Others
- China Isotope & Radiation
- Dongcheng
- Jaco
- Ciaeriar
- Advanced Molecular-imaging Solution
- Shanghai Atom Kexing
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Nuclear Medicine & Radiopharmaceuticals product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Nuclear Medicine & Radiopharmaceuticals, with price, sales, revenue and global market share of Nuclear Medicine & Radiopharmaceuticals from 2019 to 2024.
Chapter 3, the Nuclear Medicine & Radiopharmaceuticals competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nuclear Medicine & Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Nuclear Medicine & Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Nuclear Medicine & Radiopharmaceuticals.
Chapter 14 and 15, to describe Nuclear Medicine & Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Nuclear Medicine & Radiopharmaceuticals
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Diagnostic
1.3.3 Therapeutic
1.4 Market Analysis by Application
1.4.1 Overview: Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Oncology
1.4.3 Thyroid
1.4.4 Cardiology
1.4.5 Others
1.5 Global Nuclear Medicine & Radiopharmaceuticals Market Size & Forecast
1.5.1 Global Nuclear Medicine & Radiopharmaceuticals Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity (2019-2030)
1.5.3 Global Nuclear Medicine & Radiopharmaceuticals Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 China Isotope & Radiation
2.1.1 China Isotope & Radiation Details
2.1.2 China Isotope & Radiation Major Business
2.1.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product and Services
2.1.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 China Isotope & Radiation Recent Developments/Updates
2.2 Dongcheng
2.2.1 Dongcheng Details
2.2.2 Dongcheng Major Business
2.2.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Product and Services
2.2.4 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Dongcheng Recent Developments/Updates
2.3 Jaco
2.3.1 Jaco Details
2.3.2 Jaco Major Business
2.3.3 Jaco Nuclear Medicine & Radiopharmaceuticals Product and Services
2.3.4 Jaco Nuclear Medicine & Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Jaco Recent Developments/Updates
2.4 Ciaeriar
2.4.1 Ciaeriar Details
2.4.2 Ciaeriar Major Business
2.4.3 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product and Services
2.4.4 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Ciaeriar Recent Developments/Updates
2.5 Advanced Molecular-imaging Solution
2.5.1 Advanced Molecular-imaging Solution Details
2.5.2 Advanced Molecular-imaging Solution Major Business
2.5.3 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product and Services
2.5.4 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Advanced Molecular-imaging Solution Recent Developments/Updates
2.6 Shanghai Atom Kexing
2.6.1 Shanghai Atom Kexing Details
2.6.2 Shanghai Atom Kexing Major Business
2.6.3 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product and Services
2.6.4 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Shanghai Atom Kexing Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: NUCLEAR MEDICINE & RADIOPHARMACEUTICALS BY MANUFACTURER
3.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Manufacturer (2019-2024)
3.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturer (2019-2024)
3.3 Global Nuclear Medicine & Radiopharmaceuticals Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Nuclear Medicine & Radiopharmaceuticals by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Nuclear Medicine & Radiopharmaceuticals Manufacturer Market Share in 2023
3.4.2 Top 6 Nuclear Medicine & Radiopharmaceuticals Manufacturer Market Share in 2023
3.5 Nuclear Medicine & Radiopharmaceuticals Market: Overall Company Footprint Analysis
3.5.1 Nuclear Medicine & Radiopharmaceuticals Market: Region Footprint
3.5.2 Nuclear Medicine & Radiopharmaceuticals Market: Company Product Type Footprint
3.5.3 Nuclear Medicine & Radiopharmaceuticals Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Region
4.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Region (2019-2030)
4.1.2 Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Region (2019-2030)
4.1.3 Global Nuclear Medicine & Radiopharmaceuticals Average Price by Region (2019-2030)
4.2 North America Nuclear Medicine & Radiopharmaceuticals Consumption Value (2019-2030)
4.3 Europe Nuclear Medicine & Radiopharmaceuticals Consumption Value (2019-2030)
4.4 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Value (2019-2030)
4.5 South America Nuclear Medicine & Radiopharmaceuticals Consumption Value (2019-2030)
4.6 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2019-2030)
5.2 Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Type (2019-2030)
5.3 Global Nuclear Medicine & Radiopharmaceuticals Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2019-2030)
6.2 Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Application (2019-2030)
6.3 Global Nuclear Medicine & Radiopharmaceuticals Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2019-2030)
7.2 North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2019-2030)
7.3 North America Nuclear Medicine & Radiopharmaceuticals Market Size by Country
7.3.1 North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2019-2030)
7.3.2 North America Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2019-2030)
8.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2019-2030)
8.3 Europe Nuclear Medicine & Radiopharmaceuticals Market Size by Country
8.3.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2019-2030)
8.3.2 Europe Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size by Region
9.3.1 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2019-2030)
10.2 South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2019-2030)
10.3 South America Nuclear Medicine & Radiopharmaceuticals Market Size by Country
10.3.1 South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2019-2030)
10.3.2 South America Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Market Size by Country
11.3.1 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Nuclear Medicine & Radiopharmaceuticals Market Drivers
12.2 Nuclear Medicine & Radiopharmaceuticals Market Restraints
12.3 Nuclear Medicine & Radiopharmaceuticals Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Nuclear Medicine & Radiopharmaceuticals and Key Manufacturers
13.2 Manufacturing Costs Percentage of Nuclear Medicine & Radiopharmaceuticals
13.3 Nuclear Medicine & Radiopharmaceuticals Production Process
13.4 Nuclear Medicine & Radiopharmaceuticals Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Nuclear Medicine & Radiopharmaceuticals Typical Distributors
14.3 Nuclear Medicine & Radiopharmaceuticals Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Nuclear Medicine & Radiopharmaceuticals
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Diagnostic
1.3.3 Therapeutic
1.4 Market Analysis by Application
1.4.1 Overview: Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Oncology
1.4.3 Thyroid
1.4.4 Cardiology
1.4.5 Others
1.5 Global Nuclear Medicine & Radiopharmaceuticals Market Size & Forecast
1.5.1 Global Nuclear Medicine & Radiopharmaceuticals Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity (2019-2030)
1.5.3 Global Nuclear Medicine & Radiopharmaceuticals Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 China Isotope & Radiation
2.1.1 China Isotope & Radiation Details
2.1.2 China Isotope & Radiation Major Business
2.1.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product and Services
2.1.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 China Isotope & Radiation Recent Developments/Updates
2.2 Dongcheng
2.2.1 Dongcheng Details
2.2.2 Dongcheng Major Business
2.2.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Product and Services
2.2.4 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Dongcheng Recent Developments/Updates
2.3 Jaco
2.3.1 Jaco Details
2.3.2 Jaco Major Business
2.3.3 Jaco Nuclear Medicine & Radiopharmaceuticals Product and Services
2.3.4 Jaco Nuclear Medicine & Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Jaco Recent Developments/Updates
2.4 Ciaeriar
2.4.1 Ciaeriar Details
2.4.2 Ciaeriar Major Business
2.4.3 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product and Services
2.4.4 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Ciaeriar Recent Developments/Updates
2.5 Advanced Molecular-imaging Solution
2.5.1 Advanced Molecular-imaging Solution Details
2.5.2 Advanced Molecular-imaging Solution Major Business
2.5.3 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product and Services
2.5.4 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Advanced Molecular-imaging Solution Recent Developments/Updates
2.6 Shanghai Atom Kexing
2.6.1 Shanghai Atom Kexing Details
2.6.2 Shanghai Atom Kexing Major Business
2.6.3 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product and Services
2.6.4 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Shanghai Atom Kexing Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: NUCLEAR MEDICINE & RADIOPHARMACEUTICALS BY MANUFACTURER
3.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Manufacturer (2019-2024)
3.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturer (2019-2024)
3.3 Global Nuclear Medicine & Radiopharmaceuticals Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Nuclear Medicine & Radiopharmaceuticals by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Nuclear Medicine & Radiopharmaceuticals Manufacturer Market Share in 2023
3.4.2 Top 6 Nuclear Medicine & Radiopharmaceuticals Manufacturer Market Share in 2023
3.5 Nuclear Medicine & Radiopharmaceuticals Market: Overall Company Footprint Analysis
3.5.1 Nuclear Medicine & Radiopharmaceuticals Market: Region Footprint
3.5.2 Nuclear Medicine & Radiopharmaceuticals Market: Company Product Type Footprint
3.5.3 Nuclear Medicine & Radiopharmaceuticals Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Region
4.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Region (2019-2030)
4.1.2 Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Region (2019-2030)
4.1.3 Global Nuclear Medicine & Radiopharmaceuticals Average Price by Region (2019-2030)
4.2 North America Nuclear Medicine & Radiopharmaceuticals Consumption Value (2019-2030)
4.3 Europe Nuclear Medicine & Radiopharmaceuticals Consumption Value (2019-2030)
4.4 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Value (2019-2030)
4.5 South America Nuclear Medicine & Radiopharmaceuticals Consumption Value (2019-2030)
4.6 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2019-2030)
5.2 Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Type (2019-2030)
5.3 Global Nuclear Medicine & Radiopharmaceuticals Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2019-2030)
6.2 Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Application (2019-2030)
6.3 Global Nuclear Medicine & Radiopharmaceuticals Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2019-2030)
7.2 North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2019-2030)
7.3 North America Nuclear Medicine & Radiopharmaceuticals Market Size by Country
7.3.1 North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2019-2030)
7.3.2 North America Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2019-2030)
8.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2019-2030)
8.3 Europe Nuclear Medicine & Radiopharmaceuticals Market Size by Country
8.3.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2019-2030)
8.3.2 Europe Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size by Region
9.3.1 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2019-2030)
10.2 South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2019-2030)
10.3 South America Nuclear Medicine & Radiopharmaceuticals Market Size by Country
10.3.1 South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2019-2030)
10.3.2 South America Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Market Size by Country
11.3.1 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Nuclear Medicine & Radiopharmaceuticals Market Drivers
12.2 Nuclear Medicine & Radiopharmaceuticals Market Restraints
12.3 Nuclear Medicine & Radiopharmaceuticals Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Nuclear Medicine & Radiopharmaceuticals and Key Manufacturers
13.2 Manufacturing Costs Percentage of Nuclear Medicine & Radiopharmaceuticals
13.3 Nuclear Medicine & Radiopharmaceuticals Production Process
13.4 Nuclear Medicine & Radiopharmaceuticals Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Nuclear Medicine & Radiopharmaceuticals Typical Distributors
14.3 Nuclear Medicine & Radiopharmaceuticals Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 4. China Isotope & Radiation Major Business
Table 5. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product and Services
Table 6. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. China Isotope & Radiation Recent Developments/Updates
Table 8. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 9. Dongcheng Major Business
Table 10. Dongcheng Nuclear Medicine & Radiopharmaceuticals Product and Services
Table 11. Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Dongcheng Recent Developments/Updates
Table 13. Jaco Basic Information, Manufacturing Base and Competitors
Table 14. Jaco Major Business
Table 15. Jaco Nuclear Medicine & Radiopharmaceuticals Product and Services
Table 16. Jaco Nuclear Medicine & Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Jaco Recent Developments/Updates
Table 18. Ciaeriar Basic Information, Manufacturing Base and Competitors
Table 19. Ciaeriar Major Business
Table 20. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product and Services
Table 21. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Ciaeriar Recent Developments/Updates
Table 23. Advanced Molecular-imaging Solution Basic Information, Manufacturing Base and Competitors
Table 24. Advanced Molecular-imaging Solution Major Business
Table 25. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product and Services
Table 26. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Advanced Molecular-imaging Solution Recent Developments/Updates
Table 28. Shanghai Atom Kexing Basic Information, Manufacturing Base and Competitors
Table 29. Shanghai Atom Kexing Major Business
Table 30. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product and Services
Table 31. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Shanghai Atom Kexing Recent Developments/Updates
Table 33. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 34. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturer (2019-2024) & (USD Million)
Table 35. Global Nuclear Medicine & Radiopharmaceuticals Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 36. Market Position of Manufacturers in Nuclear Medicine & Radiopharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 37. Head Office and Nuclear Medicine & Radiopharmaceuticals Production Site of Key Manufacturer
Table 38. Nuclear Medicine & Radiopharmaceuticals Market: Company Product Type Footprint
Table 39. Nuclear Medicine & Radiopharmaceuticals Market: Company Product Application Footprint
Table 40. Nuclear Medicine & Radiopharmaceuticals New Market Entrants and Barriers to Market Entry
Table 41. Nuclear Medicine & Radiopharmaceuticals Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Region (2019-2024) & (K Units)
Table 43. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Region (2025-2030) & (K Units)
Table 44. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Region (2019-2024) & (USD Million)
Table 45. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Region (2025-2030) & (USD Million)
Table 46. Global Nuclear Medicine & Radiopharmaceuticals Average Price by Region (2019-2024) & (USD/Unit)
Table 47. Global Nuclear Medicine & Radiopharmaceuticals Average Price by Region (2025-2030) & (USD/Unit)
Table 48. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 49. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 50. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Type (2019-2024) & (USD Million)
Table 51. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Type (2025-2030) & (USD Million)
Table 52. Global Nuclear Medicine & Radiopharmaceuticals Average Price by Type (2019-2024) & (USD/Unit)
Table 53. Global Nuclear Medicine & Radiopharmaceuticals Average Price by Type (2025-2030) & (USD/Unit)
Table 54. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 55. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 56. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Application (2019-2024) & (USD Million)
Table 57. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Application (2025-2030) & (USD Million)
Table 58. Global Nuclear Medicine & Radiopharmaceuticals Average Price by Application (2019-2024) & (USD/Unit)
Table 59. Global Nuclear Medicine & Radiopharmaceuticals Average Price by Application (2025-2030) & (USD/Unit)
Table 60. North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 61. North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 62. North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 63. North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 64. North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2019-2024) & (K Units)
Table 65. North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2025-2030) & (K Units)
Table 66. North America Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2019-2024) & (USD Million)
Table 67. North America Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2025-2030) & (USD Million)
Table 68. Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 71. Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 72. Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2019-2024) & (K Units)
Table 73. Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2025-2030) & (K Units)
Table 74. Europe Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 77. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 78. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 79. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 80. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Region (2019-2024) & (K Units)
Table 81. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Region (2025-2030) & (K Units)
Table 82. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Value by Region (2019-2024) & (USD Million)
Table 83. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Value by Region (2025-2030) & (USD Million)
Table 84. South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 85. South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 86. South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 87. South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 88. South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2019-2024) & (K Units)
Table 89. South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2025-2030) & (K Units)
Table 90. South America Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2019-2024) & (USD Million)
Table 91. South America Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2025-2030) & (USD Million)
Table 92. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 93. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 94. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 95. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 96. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Region (2019-2024) & (K Units)
Table 97. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Region (2025-2030) & (K Units)
Table 98. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption Value by Region (2019-2024) & (USD Million)
Table 99. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption Value by Region (2025-2030) & (USD Million)
Table 100. Nuclear Medicine & Radiopharmaceuticals Raw Material
Table 101. Key Manufacturers of Nuclear Medicine & Radiopharmaceuticals Raw Materials
Table 102. Nuclear Medicine & Radiopharmaceuticals Typical Distributors
Table 103. Nuclear Medicine & Radiopharmaceuticals Typical Customers
Table 1. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 4. China Isotope & Radiation Major Business
Table 5. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product and Services
Table 6. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. China Isotope & Radiation Recent Developments/Updates
Table 8. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 9. Dongcheng Major Business
Table 10. Dongcheng Nuclear Medicine & Radiopharmaceuticals Product and Services
Table 11. Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Dongcheng Recent Developments/Updates
Table 13. Jaco Basic Information, Manufacturing Base and Competitors
Table 14. Jaco Major Business
Table 15. Jaco Nuclear Medicine & Radiopharmaceuticals Product and Services
Table 16. Jaco Nuclear Medicine & Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Jaco Recent Developments/Updates
Table 18. Ciaeriar Basic Information, Manufacturing Base and Competitors
Table 19. Ciaeriar Major Business
Table 20. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product and Services
Table 21. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Ciaeriar Recent Developments/Updates
Table 23. Advanced Molecular-imaging Solution Basic Information, Manufacturing Base and Competitors
Table 24. Advanced Molecular-imaging Solution Major Business
Table 25. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product and Services
Table 26. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Advanced Molecular-imaging Solution Recent Developments/Updates
Table 28. Shanghai Atom Kexing Basic Information, Manufacturing Base and Competitors
Table 29. Shanghai Atom Kexing Major Business
Table 30. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product and Services
Table 31. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Shanghai Atom Kexing Recent Developments/Updates
Table 33. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 34. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturer (2019-2024) & (USD Million)
Table 35. Global Nuclear Medicine & Radiopharmaceuticals Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 36. Market Position of Manufacturers in Nuclear Medicine & Radiopharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 37. Head Office and Nuclear Medicine & Radiopharmaceuticals Production Site of Key Manufacturer
Table 38. Nuclear Medicine & Radiopharmaceuticals Market: Company Product Type Footprint
Table 39. Nuclear Medicine & Radiopharmaceuticals Market: Company Product Application Footprint
Table 40. Nuclear Medicine & Radiopharmaceuticals New Market Entrants and Barriers to Market Entry
Table 41. Nuclear Medicine & Radiopharmaceuticals Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Region (2019-2024) & (K Units)
Table 43. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Region (2025-2030) & (K Units)
Table 44. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Region (2019-2024) & (USD Million)
Table 45. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Region (2025-2030) & (USD Million)
Table 46. Global Nuclear Medicine & Radiopharmaceuticals Average Price by Region (2019-2024) & (USD/Unit)
Table 47. Global Nuclear Medicine & Radiopharmaceuticals Average Price by Region (2025-2030) & (USD/Unit)
Table 48. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 49. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 50. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Type (2019-2024) & (USD Million)
Table 51. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Type (2025-2030) & (USD Million)
Table 52. Global Nuclear Medicine & Radiopharmaceuticals Average Price by Type (2019-2024) & (USD/Unit)
Table 53. Global Nuclear Medicine & Radiopharmaceuticals Average Price by Type (2025-2030) & (USD/Unit)
Table 54. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 55. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 56. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Application (2019-2024) & (USD Million)
Table 57. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Application (2025-2030) & (USD Million)
Table 58. Global Nuclear Medicine & Radiopharmaceuticals Average Price by Application (2019-2024) & (USD/Unit)
Table 59. Global Nuclear Medicine & Radiopharmaceuticals Average Price by Application (2025-2030) & (USD/Unit)
Table 60. North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 61. North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 62. North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 63. North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 64. North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2019-2024) & (K Units)
Table 65. North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2025-2030) & (K Units)
Table 66. North America Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2019-2024) & (USD Million)
Table 67. North America Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2025-2030) & (USD Million)
Table 68. Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 71. Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 72. Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2019-2024) & (K Units)
Table 73. Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2025-2030) & (K Units)
Table 74. Europe Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 77. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 78. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 79. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 80. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Region (2019-2024) & (K Units)
Table 81. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Region (2025-2030) & (K Units)
Table 82. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Value by Region (2019-2024) & (USD Million)
Table 83. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Value by Region (2025-2030) & (USD Million)
Table 84. South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 85. South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 86. South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 87. South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 88. South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2019-2024) & (K Units)
Table 89. South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2025-2030) & (K Units)
Table 90. South America Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2019-2024) & (USD Million)
Table 91. South America Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2025-2030) & (USD Million)
Table 92. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 93. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 94. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 95. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 96. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Region (2019-2024) & (K Units)
Table 97. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Region (2025-2030) & (K Units)
Table 98. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption Value by Region (2019-2024) & (USD Million)
Table 99. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption Value by Region (2025-2030) & (USD Million)
Table 100. Nuclear Medicine & Radiopharmaceuticals Raw Material
Table 101. Key Manufacturers of Nuclear Medicine & Radiopharmaceuticals Raw Materials
Table 102. Nuclear Medicine & Radiopharmaceuticals Typical Distributors
Table 103. Nuclear Medicine & Radiopharmaceuticals Typical Customers
LIST OF FIGURES
Figure 1. Nuclear Medicine & Radiopharmaceuticals Picture
Figure 2. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Type in 2023
Figure 4. Diagnostic Examples
Figure 5. Therapeutic Examples
Figure 6. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Application in 2023
Figure 8. Oncology Examples
Figure 9. Thyroid Examples
Figure 10. Cardiology Examples
Figure 11. Others Examples
Figure 12. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity (2019-2030) & (K Units)
Figure 15. Global Nuclear Medicine & Radiopharmaceuticals Average Price (2019-2030) & (USD/Unit)
Figure 16. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Nuclear Medicine & Radiopharmaceuticals by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Nuclear Medicine & Radiopharmaceuticals Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Nuclear Medicine & Radiopharmaceuticals Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Nuclear Medicine & Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Nuclear Medicine & Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Nuclear Medicine & Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Nuclear Medicine & Radiopharmaceuticals Average Price by Type (2019-2030) & (USD/Unit)
Figure 31. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Nuclear Medicine & Radiopharmaceuticals Average Price by Application (2019-2030) & (USD/Unit)
Figure 34. North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Region (2019-2030)
Figure 54. China Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Nuclear Medicine & Radiopharmaceuticals Market Drivers
Figure 75. Nuclear Medicine & Radiopharmaceuticals Market Restraints
Figure 76. Nuclear Medicine & Radiopharmaceuticals Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Nuclear Medicine & Radiopharmaceuticals in 2023
Figure 79. Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceuticals
Figure 80. Nuclear Medicine & Radiopharmaceuticals Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Nuclear Medicine & Radiopharmaceuticals Picture
Figure 2. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Type in 2023
Figure 4. Diagnostic Examples
Figure 5. Therapeutic Examples
Figure 6. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Application in 2023
Figure 8. Oncology Examples
Figure 9. Thyroid Examples
Figure 10. Cardiology Examples
Figure 11. Others Examples
Figure 12. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity (2019-2030) & (K Units)
Figure 15. Global Nuclear Medicine & Radiopharmaceuticals Average Price (2019-2030) & (USD/Unit)
Figure 16. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Nuclear Medicine & Radiopharmaceuticals by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Nuclear Medicine & Radiopharmaceuticals Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Nuclear Medicine & Radiopharmaceuticals Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Nuclear Medicine & Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Nuclear Medicine & Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Nuclear Medicine & Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Nuclear Medicine & Radiopharmaceuticals Average Price by Type (2019-2030) & (USD/Unit)
Figure 31. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Nuclear Medicine & Radiopharmaceuticals Average Price by Application (2019-2030) & (USD/Unit)
Figure 34. North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Region (2019-2030)
Figure 54. China Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Nuclear Medicine & Radiopharmaceuticals Market Drivers
Figure 75. Nuclear Medicine & Radiopharmaceuticals Market Restraints
Figure 76. Nuclear Medicine & Radiopharmaceuticals Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Nuclear Medicine & Radiopharmaceuticals in 2023
Figure 79. Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceuticals
Figure 80. Nuclear Medicine & Radiopharmaceuticals Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
